Pavel Uhrin
Overview
Explore the profile of Pavel Uhrin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Khan S, Awad E, Oszwald A, Mayr M, Yin X, Waltenberger B, et al.
Sci Rep
. 2017 Jan;
7:39501.
PMID: 28045034
Cellular senescence is characterized by a permanent cell-cycle arrest and a pro-inflammatory secretory phenotype, and can be induced by a variety of stimuli, including ionizing radiation, oxidative stress, and inflammation....
22.
23.
Cicvaric A, Yang J, Krieger S, Khan D, Kim E, Dominguez-Rodriguez M, et al.
Ann Med
. 2016 Aug;
48(8):652-668.
PMID: 27558977
Introduction: Podoplanin is a cell-surface glycoprotein constitutively expressed in the brain and implicated in human brain tumorigenesis. The intrinsic function of podoplanin in brain neurons remains however uncharacterized. Materials And...
24.
Heiss E, Liu R, Waltenberger B, Khan S, Schachner D, Kollmann P, et al.
Sci Rep
. 2016 Feb;
6:20771.
PMID: 26858089
The etiology of atherosclerosis and restenosis involves aberrant inflammation and proliferation, rendering compounds with both anti-inflammatory and anti-mitogenic properties as promising candidates for combatting vascular diseases. A recent study identified...
25.
Blazevic T, Heiss E, Atanasov A, Breuss J, Dirsch V, Uhrin P
Evid Based Complement Alternat Med
. 2015 Oct;
2015:654098.
PMID: 26457112
Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine formulation. The encouraging clinical results from the 1980s obtained in chronic myelocytic leukemia patients treated with indirubin...
26.
Yang H, Wahlmuller F, Uhrin P, Baumgartner R, Mitulovic G, Sarg B, et al.
Electrophoresis
. 2015 Sep;
36(21-22):2837-2840.
PMID: 26332751
Serine protease inhibitors (serpin) have therapeutic potential in a variety of pathogenic processes, ranging from thrombosis and altered immune response to liver cirrhosis. To investigate the physiological effects of protein...
27.
Atanasov A, Waltenberger B, Pferschy-Wenzig E, Linder T, Wawrosch C, Uhrin P, et al.
Biotechnol Adv
. 2015 Aug;
33(8):1582-1614.
PMID: 26281720
Medicinal plants have historically proven their value as a source of molecules with therapeutic potential, and nowadays still represent an important pool for the identification of novel drug leads. In...
28.
Unseld M, Breuss J, Pausz C, Pablik E, Schabbauer G, Zielinski C, et al.
J Vasc Res
. 2015 Aug;
52(2):116-26.
PMID: 26277802
Background: Angiogenesis, the formation of new blood vessels, is an essential process under physiological and pathological conditions. Method: Here, we improved the directed in vivo angiogenesis assay (DIVAA®) test, which...
29.
Brunner P, Glitzner E, Reininger B, Klein I, Stary G, Mildner M, et al.
Exp Dermatol
. 2015 Apr;
24(7):522-8.
PMID: 25828150
Chemokines are small chemotactic proteins that have a crucial role in leukocyte recruitment into tissue. Targeting these mediators has been suggested as a potential therapeutic option in inflammatory skin diseases...
30.
Zieger M, Ahnelt P, Uhrin P
PLoS One
. 2014 Sep;
9(9):e106562.
PMID: 25191897
We aimed to investigate fractalkine (CX3CL1) protein expression in wild type (wt) retina and its alterations during retinal degeneration in mouse model (rd10) of retinitis pigmentosa. Forms of retinal protein...